These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Allergic conjunctivitis in children]. Zepeda Ortega B; Rosas Vargas MA; Ito Tsuchiya FM; del Río Navarro BE; Sienra Monge JJ Rev Alerg Mex; 2007; 54(2):41-53. PubMed ID: 17542245 [TBL] [Abstract][Full Text] [Related]
27. [The role of chemokines in ocular diseases. Part II. Participation of chemokines in ocular diseases]. Malesiński R; Mrugacz M; Bakunowicz-Łazarczyk A Klin Oczna; 2007; 109(7-9):345-8. PubMed ID: 18260295 [TBL] [Abstract][Full Text] [Related]
28. Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis. Schechter BA Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):507-11. PubMed ID: 18433352 [TBL] [Abstract][Full Text] [Related]
29. A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs. Yanni JM; Sharif NA; Gamache DA; Miller ST; Weimer LK; Spellman JM Acta Ophthalmol Scand Suppl; 1999; (228):33-7. PubMed ID: 10337430 [TBL] [Abstract][Full Text] [Related]
30. CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer. Fukagawa K; Okada N; Fujishima H; Nakajima T; Tsubota K; Takano Y; Kawasaki H; Saito H; Hirai K Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):58-62. PubMed ID: 11773013 [TBL] [Abstract][Full Text] [Related]
32. [What's new in ocular surface disease?]. Messmer EM; Benitez-Del-Castillo JM; Lambiase A; Doan S Ophthalmologe; 2005 Mar; 102(3):293-300. PubMed ID: 15616816 [TBL] [Abstract][Full Text] [Related]
33. The ocular surface: from physiology to the ocular allergic diseases. Galicia-Carreón J; Santacruz C; Hong E; Jiménez-Martínez MC Rev Alerg Mex; 2013; 60(4):172-83. PubMed ID: 24912910 [TBL] [Abstract][Full Text] [Related]
34. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. Ono SJ; Abelson MB J Allergy Clin Immunol; 2005 Jan; 115(1):118-22. PubMed ID: 15637556 [TBL] [Abstract][Full Text] [Related]
35. Fibrosis in ocular allergic inflammation: recent concepts in the pathogenesis of ocular allergy. Solomon A; Puxeddu I; Levi-Schaffer F Curr Opin Allergy Clin Immunol; 2003 Oct; 3(5):389-93. PubMed ID: 14501440 [TBL] [Abstract][Full Text] [Related]
36. Allergy and allergic mediators in tears. Leonardi A Exp Eye Res; 2013 Dec; 117():106-17. PubMed ID: 23891862 [TBL] [Abstract][Full Text] [Related]
37. Clinical implications of mast cell involvement in allergic conjunctivitis. Elieh Ali Komi D; Rambasek T; Bielory L Allergy; 2018 Mar; 73(3):528-539. PubMed ID: 29105783 [TBL] [Abstract][Full Text] [Related]
38. The role of histamine in ocular allergy. Ohbayashi M; Manzouri B; Morohoshi K; Fukuda K; Ono SJ Adv Exp Med Biol; 2010; 709():43-52. PubMed ID: 21618886 [TBL] [Abstract][Full Text] [Related]